DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock
Abstract Aims The DanGer Shock (DGS) trial demonstrated that the routine use of a microaxial flow pump (mAFP) with standard care to treat STEMI‐related cardiogenic shock (STEMI‐CS) led to a lower risk of all‐cause death at 180 days than standard care alone. We investigated the impact of patient elig...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2025-08-01
|
| Schriftenreihe: | ESC Heart Failure |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/ehf2.15269 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|